Results 51 to 60 of about 33,486 (230)
Higher Rate of Extreme Drug-resistant Klebsiella pneumoniae Infections among Cardiac Patients
Journal of Nepal Health Research Council, 2022 Background: The accelerating rate of carbapenems resistance in Klebseilla pneumoniae isolates has put the treatment option worrisome. The effective strategy to ameliorate this alarming situation is possible through enhancing the combination therapy and ...
Subash Paudel +4 more
doaj +1 more source
Pathogens, 2023 (1) Background: Pseudomonas aeruginosa is a Gram-negative bacterium with several intrinsic and acquired antimicrobial resistance mechanisms. The spread of carbapenemase-encoding genes, an acquired mechanism, enables carbapenem resistance in clinical ...
María Guadalupe Martínez-Zavaleta +7 more
doaj +1 more source
Mobile Carbapenemase Genes in Pseudomonas aeruginosa [PDF]
Frontiers in Microbiology, 2021 Carbapenem-resistantPseudomonas aeruginosais one of the major concerns in clinical settings impelling a great challenge to antimicrobial therapy for patients with infections caused by the pathogen. While membrane permeability, together with derepression of the intrinsic beta-lactamase gene, is the global prevailing mechanism of carbapenem resistance ...
Eun-Jeong Yoon, Seok Hoon Jeong
openaire +4 more sources
Microbiology SpectrumCarbapenemase-producing Enterobacterales (CPE) is a diverse group of often multidrug-resistant organisms. Surveillance and control of infections are complicated due to the inter-species spread of carbapenemase-encoding genes (CEGs) on mobile genetic ...
Mark Maguire +15 more
doaj +1 more source
Annals of Clinical Microbiology and Antimicrobials, 2020 Background Antimicrobial resistance among nosocomial Gram-negative pathogens is a cause for concern in the Asia–Pacific region. The aims of this study were to measure the rates of resistance among clinical isolates collected in Asia–Pacific countries ...
Wen-Chien Ko, Gregory G. Stone
doaj +1 more source
Carbapenemase-Producing Organisms: A Global Scourge [PDF]
Clinical Infectious Diseases, 2017 The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern. Carbapenemase production is especially problematic when encountered in members of the family Enterobacteriaceae.
Bonomo, Robert A +6 more
openaire +3 more sources
, 2017 Carbapenemase-producing Enterobacteriaceae subjected to the CIM method, compared to the Carba NP test.
Laurent Dortet (211094) +3 more
core +1 more source
, 2019 Carbapenems are usually regarded as the last treatment option for serious infections caused by Gram-negative and Gram-positive microorganisms. Although they are stable to hydrolysis by most β- lactamases, their usage as the last resort antbiotics was seriously compromised by the appearance of carbapenem-hydrolyzing enzymes called carbapenemases.
Bedenić, Branka, Sardelić, Sanda
openaire +2 more sources
, 2014 Among 15 174 non-duplicated Enterobacteriaceae isolates, the prevalence of carbapenem-nonsusceptible Enterobacteriaceae (CNSE) was about 2.5% at a teaching hospital in Taiwan during 2010.
張上淳 ;王振泰 ;賴志政 +1 more
core +1 more source
Frequency of Carbapenemase Producing Klebsiella pneumoniae in Makkah, Saudi Arabia
Journal of Microbiology and Infectious Diseases, 2016 Objective: Carbapenemase producing Klebsiella pneumoniae is emerging as an important pathogen worldwide which has alarming clinical threat with serious effects on patients ' outcome.
Mubashir Ahmad Khan, Aftab Faiz
doaj +1 more source